Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups

Molecular pathogenesis of multiple myeloma: basic and clinical updates

(2013) Marta Chesi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Apoptotic Machinery Diversity in Multiple Myeloma Molecular Subtypes

(2013) Patricia Gomez-Bougie et al.   Frontiers in Immunology

Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: A randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study

(2012) Terry Golombick et al.   AMERICAN JOURNAL OF HEMATOLOGY

Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells

(2012) S. Surget et al.   CANCER RESEARCH

ABT-737 is highly effective against molecular subgroups of multiple myeloma

(2011) L. Bodet et al.   BLOOD

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma

(2011) Sarah K. Johnson et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Current Trends in Autologous Stem-Cell Transplantation for Myeloma in the Era of Novel Therapies

(2011) Philippe Moreau et al.   JOURNAL OF CLINICAL ONCOLOGY

Emerging Bcl-2 inhibitors for the treatment of cancer

(2010) Asfar S Azmi et al.   EXPERT OPINION ON EMERGING DRUGS

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma

(2010) L. Lode et al.   HAEMATOLOGICA

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

(2010) J. Moreaux et al.   HAEMATOLOGICA

Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model

(2009) B. Sung et al.   MOLECULAR CANCER THERAPEUTICS

Curcumin Inhibits the Proteasome Activity in Human Colon Cancer Cells In vitro and In vivo

(2008) V. Milacic et al.   CANCER RESEARCH

Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells

(2008) Juwon Park et al.   Molecular Oncology